1. Home
  2. EXEL vs WMS Comparison

EXEL vs WMS Comparison

Compare EXEL & WMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • WMS
  • Stock Information
  • Founded
  • EXEL 1994
  • WMS 1966
  • Country
  • EXEL United States
  • WMS United States
  • Employees
  • EXEL N/A
  • WMS N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • WMS Containers/Packaging
  • Sector
  • EXEL Health Care
  • WMS Consumer Discretionary
  • Exchange
  • EXEL Nasdaq
  • WMS Nasdaq
  • Market Cap
  • EXEL 10.4B
  • WMS 11.2B
  • IPO Year
  • EXEL 2000
  • WMS 2014
  • Fundamental
  • Price
  • EXEL $38.94
  • WMS $139.09
  • Analyst Decision
  • EXEL Buy
  • WMS Strong Buy
  • Analyst Count
  • EXEL 22
  • WMS 9
  • Target Price
  • EXEL $44.10
  • WMS $153.11
  • AVG Volume (30 Days)
  • EXEL 2.9M
  • WMS 604.7K
  • Earning Date
  • EXEL 11-04-2025
  • WMS 11-06-2025
  • Dividend Yield
  • EXEL N/A
  • WMS 0.52%
  • EPS Growth
  • EXEL 81.76
  • WMS N/A
  • EPS
  • EXEL 2.08
  • WMS 5.54
  • Revenue
  • EXEL $2,230,005,000.00
  • WMS $2,918,789,000.00
  • Revenue This Year
  • EXEL $9.14
  • WMS $2.26
  • Revenue Next Year
  • EXEL $12.59
  • WMS $5.35
  • P/E Ratio
  • EXEL $18.75
  • WMS $25.11
  • Revenue Growth
  • EXEL 10.73
  • WMS 0.24
  • 52 Week Low
  • EXEL $31.18
  • WMS $93.92
  • 52 Week High
  • EXEL $49.62
  • WMS $166.03
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 50.54
  • WMS 46.89
  • Support Level
  • EXEL $33.76
  • WMS $137.83
  • Resistance Level
  • EXEL $40.63
  • WMS $142.91
  • Average True Range (ATR)
  • EXEL 1.30
  • WMS 3.75
  • MACD
  • EXEL 0.17
  • WMS -0.17
  • Stochastic Oscillator
  • EXEL 75.47
  • WMS 49.08

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About WMS Advanced Drainage Systems Inc.

Advanced Drainage Systems Inc is the manufacturer of water management solutions in the stormwater and onsite septic wastewater industries, providing superior drainage solutions for use in the construction and agriculture marketplaces. Its products are used across a broad range of end markets and applications, including residential, non-residential, infrastructure and agriculture applications. It operates business in three distinct reportable segments: Pipe; International, and Infiltrator. It generates a greater proportion of revenue from its Pipe segment, which consists of Pipe product sales in the United States. The Infiltrator is a provider of plastic leachfield chambers and systems, septic tanks and accessories, for use in residential applications.

Share on Social Networks: